Tarek Mekhail - Concepedia

Author

Tarek Mekhail

Also Known As

Hsu, Vincent, Manoucheri, M., Mekhail, Tarek, T M Mekhail, T MEKHAIL, T. M. Mekhail, T. Mekhail, T.M. Mekhail, Tarek M Mekhail, Tarek M. Mekhail

258

Publications

21.7K

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Florida Hospital Cancer Institute Dana-Farber Cancer Institute AdventHealth Orlando Memorial Sloan Kettering Cancer Center

About

Tarek Mekhail is an author at Cleveland Clinic specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	54	4.5K
2	Health Sciences	15	18	919
3	Cell Biology	3	3	71
4	Public Health	2	2	100
5	Epidemiology	1	1	16

Tarek Mekhail

Publications

20.6K

Citations

H-Index

Page 1

	Year	Citations
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer Scott Antonia, Augusto Villegas, Davey B. Daniel, New England Journal of Medicine	2017	4.4K
First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer Benjamin Solomon, Tony Mok, Dong‐Wan Kim, New England Journal of Medicine	2014	3.2K
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC Scott Antonia, Augusto Villegas, Davey B. Daniel, New England Journal of Medicine	2018	2.7K
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial Howard West, Michael McCleod, Maen Hussein, The Lancet Oncology MedicineMetronomic TherapyPharmacologyPathologyBronchial Neoplasm	2019	1.6K
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial Alice T. Shaw, Leena Gandhi, Shirish M. Gadgeel, The Lancet Oncology Non-small-cell Lung CancerMedicinePathologyBronchial NeoplasmCancer Treatment	2015	636
Detection of Lung Cancer by Sensor Array Analyses of Exhaled Breath Roberto F. Machado, Daniel Laskowski, Olivia Deffenderfer, American Journal of Respiratory and Critical Care Medicine	2005	601
Alectinib in Crizotinib-Refractory <i>ALK-</i>Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study Sai‐Hong Ignatius Ou, Jin Seok Ahn, Luigi De Petris, Journal of Clinical Oncology	2015	578
Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma Tarek Mekhail, Rony M. Abou-Jawde, Gabriel BouMerhi, Journal of Clinical Oncology	2005	569
Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non–Small-Cell Lung Cancer Benjamin Solomon, Dong‐Wan Kim, Yi‐Long Wu, Journal of Clinical Oncology	2018	406
Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Tarek Mekhail, David J. Adelstein, Lisa Rybicki, PubMed	2001	325

Page 1